104 related articles for article (PubMed ID: 27687486)
1. Small molecule induces Wnt asymmetry in cancer.
Qu Y; Kalland KH; Ke X
Cell Cycle; 2017 Jan; 16(2):141-142. PubMed ID: 27687486
[No Abstract] [Full Text] [Related]
2. Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer.
Qu Y; Gharbi N; Yuan X; Olsen JR; Blicher P; Dalhus B; Brokstad KA; Lin B; Øyan AM; Zhang W; Kalland KH; Ke X
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9339-44. PubMed ID: 27482107
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Developmental Signaling Pathway Inhibitors for the Treatment of Cancer.
Hadden MK
Curr Med Chem; 2015; 22(35):4031-2. PubMed ID: 26630931
[No Abstract] [Full Text] [Related]
4. Winning WNT: race to Wnt signaling inhibitors.
Watanabe K; Dai X
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):5929-30. PubMed ID: 21451134
[No Abstract] [Full Text] [Related]
5. Chemical Disruption of Wnt-dependent Cell Fate Decision-making Mechanisms in Cancer and Regenerative Medicine.
Lum L; Chen C
Curr Med Chem; 2015; 22(35):4091-103. PubMed ID: 26310918
[TBL] [Abstract][Full Text] [Related]
6. Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.
Camilli TC; Weeraratna AT
Biochem Pharmacol; 2010 Sep; 80(5):702-11. PubMed ID: 20211149
[TBL] [Abstract][Full Text] [Related]
7. A zebrafish chemical suppressor screening identifies small molecule inhibitors of the Wnt/β-catenin pathway.
Nishiya N; Oku Y; Kumagai Y; Sato Y; Yamaguchi E; Sasaki A; Shoji M; Ohnishi Y; Okamoto H; Uehara Y
Chem Biol; 2014 Apr; 21(4):530-540. PubMed ID: 24684907
[TBL] [Abstract][Full Text] [Related]
8. Identification of dinactin, a macrolide antibiotic, as a natural product-based small molecule targeting Wnt/β-catenin signaling pathway in cancer cells.
Hussain A; Dar MS; Bano N; Hossain MM; Basit R; Bhat AQ; Aga MA; Ali S; Hassan QP; Dar MJ
Cancer Chemother Pharmacol; 2019 Sep; 84(3):551-559. PubMed ID: 31129716
[TBL] [Abstract][Full Text] [Related]
9. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells.
Jang GB; Hong IS; Kim RJ; Lee SY; Park SJ; Lee ES; Park JH; Yun CH; Chung JU; Lee KJ; Lee HY; Nam JS
Cancer Res; 2015 Apr; 75(8):1691-702. PubMed ID: 25660951
[TBL] [Abstract][Full Text] [Related]
11. Centrosome-Associated Degradation Limits β-Catenin Inheritance by Daughter Cells after Asymmetric Division.
Vora S; Phillips BT
Curr Biol; 2015 Apr; 25(8):1005-16. PubMed ID: 25819561
[TBL] [Abstract][Full Text] [Related]
12. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.
Hwang SY; Deng X; Byun S; Lee C; Lee SJ; Suh H; Zhang J; Kang Q; Zhang T; Westover KD; Mandinova A; Lee SW
Cell Rep; 2016 Jun; 16(1):28-36. PubMed ID: 27320923
[TBL] [Abstract][Full Text] [Related]
13. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
14. JQ-1 Inhibits Colon Cancer Proliferation via Suppressing Wnt/β-Catenin Signaling and miR-21.
Zhang Y; Tian S; Xiong J; Zhou Y; Song H; Liu C
Chem Res Toxicol; 2018 May; 31(5):302-307. PubMed ID: 29600711
[TBL] [Abstract][Full Text] [Related]
15. A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/β-catenin pathway inhibitors in non-small-cell lung cancer cell lines.
Gong YD; Dong MS; Lee SB; Kim N; Bae MS; Kang NS
Bioorg Med Chem; 2011 Sep; 19(18):5639-47. PubMed ID: 21855350
[TBL] [Abstract][Full Text] [Related]
16. Blocking Wnt as a therapeutic target in mice model of skin cancer.
Alyoussef A; Taha M
Arch Dermatol Res; 2019 Oct; 311(8):595-605. PubMed ID: 31165240
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling, 3D-QSAR and DFT studies of IWR small-molecule inhibitors of Wnt response.
Kirubakaran P; Karthikeyan M
J Recept Signal Transduct Res; 2013 Oct; 33(5):276-85. PubMed ID: 23914783
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
[TBL] [Abstract][Full Text] [Related]
19. New avenues to target Wnt/β-catenin signaling.
Verkaar F; Zaman GJ
Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
[TBL] [Abstract][Full Text] [Related]
20. Mining the Wnt pathway for cancer therapeutics.
Barker N; Clevers H
Nat Rev Drug Discov; 2006 Dec; 5(12):997-1014. PubMed ID: 17139285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
